Scholarlink

<p>Although there is clear evidence for revascularization in acute coronary syndrome, the decision for revascularization in patients with chronic coronary syndrome is much more complex. The data on this topic are partly inconsistent; however, chronic stenotic coronary artery disease and its comorbidities are still among the leading causes of morbidity and mortality worldwide. The decision regarding which patients benefit most from revascularization, whether by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), is based on a&#xa0;wide variety of factors. These include the symptoms, pretest probability, the extent of myocardial ischemia, anatomical conditions and individual comorbidities. This article summarizes the current knowledge from the updated European Society of Cardiology (ESC) guidelines from 2024 and discusses key clinical studies as well as their relevance for the clinical practice. The aim is to provide a&#xa0;nuanced perspective on decision making in chronic coronary syndrome.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Chronisches Koronarsyndrom – Wann und wie interventionell revaskularisieren?

  • 期刊论文

  • 发表日期：

    2025年2月28日

查看全文
  • Johanna Bormann,
  • Tanja Rudolph

摘要

Although there is clear evidence for revascularization in acute coronary syndrome, the decision for revascularization in patients with chronic coronary syndrome is much more complex. The data on this topic are partly inconsistent; however, chronic stenotic coronary artery disease and its comorbidities are still among the leading causes of morbidity and mortality worldwide. The decision regarding which patients benefit most from revascularization, whether by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), is based on a wide variety of factors. These include the symptoms, pretest probability, the extent of myocardial ischemia, anatomical conditions and individual comorbidities. This article summarizes the current knowledge from the updated European Society of Cardiology (ESC) guidelines from 2024 and discusses key clinical studies as well as their relevance for the clinical practice. The aim is to provide a nuanced perspective on decision making in chronic coronary syndrome.